USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
GlucoSentient, Inc.
Address:
60 Hazelwood Drive
Champaign, IL 61820-0000
Phone:
N/A
URL:
N/A
EIN:
453855869
DUNS:
78305396
Number of Employees:
2
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $149,999.00 1
SBIR Phase II $750,000.00 1

Award List:

SBIR Phase I: Novel Biosensor for Monitoring of Theophylline using Personal Glucose Meter

Award Year / Program / Phase:
2012 / SBIR / Phase I
Award Amount:
$149,999.00
Agency:
NSF
Principal Investigator:
Abstract:
This Small Business Innovation Research Phase I project aims to develop a new technology to utilize ubiquitous personal glucose meters (PGMs) for inexpensive and convenient at-home tests of the drug theophylline. Theophylline has been widely used to treat asthma and chronic obstructive pulmonary… More

SBIR Phase II: A Novel Device for Convenient Therapeutic Drug Monitoring of Tacrolimus

Award Year / Program / Phase:
2013 / SBIR / Phase II
Award Amount:
$750,000.00
Agency:
NSF
Principal Investigator:
Abstract:
This Small Business Innovation Research (SBIR) Phase II project is aiming to develop and validate a point-of-care monitoring for tacrolimus, an immunosuppressive medication widely used by organ transplant patients. The product being developed combines the existing, well-developed and low cost… More